A detailed history of High Tower Advisors, LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 24,880 shares of PMVP stock, worth $40,056. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,880
Previous 25,030 0.6%
Holding current value
$40,056
Previous $40,000 7.5%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.44 - $1.69 $216 - $253
-150 Reduced 0.6%
24,880 $37,000
Q1 2023

May 11, 2023

SELL
$4.77 - $9.16 $944 - $1,813
-198 Reduced 0.78%
25,030 $119,000
Q4 2022

Feb 08, 2023

BUY
$8.17 - $12.95 $1,617 - $2,564
198 Added 0.79%
25,228 $219,000
Q3 2022

Nov 09, 2022

BUY
$11.4 - $17.18 $1,710 - $2,577
150 Added 0.6%
25,030 $298,000
Q4 2021

Feb 10, 2022

BUY
$19.99 - $30.24 $497,351 - $752,371
24,880 New
24,880 $575,000

Others Institutions Holding PMVP

About PMV Pharmaceuticals, Inc.


  • Ticker PMVP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,622,600
  • Market Cap $73.5M
  • Description
  • PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...
More about PMVP
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.